Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Are Designer Steroids Dietary Ingredients? FDA Warning Letter Skirts Issue

This article was originally published in The Tan Sheet

Executive Summary

Assuming designer steroids are dietary ingredients, they also appear to be new dietary ingredients, FDA writes in a warning letter to the online retailer Bodybuilding.com

You may also be interested in...



Steroids Sold As Supplements Targeted In FDA Actions, Congressional Hearing

Enhanced FDA enforcement against steroid products sold as dietary supplements is likely reassuring to law-abiding supplement companies

Steroids Sold As Supplements Targeted In FDA Actions, Congressional Hearing

Enhanced FDA enforcement against steroid products sold as dietary supplements is likely reassuring to law-abiding supplement companies

Steroids Sold As Supplements Targeted In FDA Actions, Congressional Hearing

Enhanced FDA enforcement against steroid products sold as dietary supplements is likely reassuring to law-abiding supplement companies

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS099622

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel